Clinical Trials - Phase III
Filter News
Found 22,557 articles
-
ZS Pharma Completes Patient Enrollment In ZS004, Its Second Phase 3 Study Of ZS-9 In Patients With Hyperkalemia
7/15/2014
-
Neos Therapeutics Announces Positive Phase 3 Study Results For Its Methylphenidate Extended-Release (XR) Oral Disintegrating Tablet (ODT) In ADHD Patients
7/15/2014
-
FDA Green Lights Starpharma Holdings Ltd's VivaGel Trial Design
7/14/2014
-
Synergy Pharmaceuticals Reaches Halfway Mark For The First Pivotal Phase 3 Trial Of Plecanatide In Patients With Chronic Idiopathic Constipation
7/14/2014
-
Alcobra Completes Patient Recruitment In Phase 3 Clinical Trial Of MDX In Adult ADHD
7/14/2014
-
Basilea Pharmaceutica Reports That Isavuconazole Receives Orphan Drug Designations In Europe For The Treatment Of Invasive Mold Infections
7/14/2014
-
Astellas Pharma Inc. Details Pipeline Progress At R&D Meeting
7/11/2014
-
Novartis AG's New Drug Secukinumab Shows Promise In Two Pivotal Phase 3 Trials
7/11/2014
-
FDA Places Regado Biosciences, Inc.'s Phase 3 Revolixys Trial On Clinical Hold
7/11/2014
-
Latest Sarepta Therapeutics Phase 2 Data Shows Greater Decline in Walking Ability For Muscular Dystrophy Patients
7/10/2014
-
Celgene's OTEZLA® Misses Mark In Phase 3 Spinal Arthritis Study
7/10/2014
-
SillaJen Lead Product Pexa-Vec Featured In "Nature Reviews Cancer" Article Summarizing The Potential Of Oncolytic Immunotherapy
7/10/2014
-
TransTech Pharma, Inc. Announces Agreement With FDA On Special Protocol Assessment For TTP488 Phase 3 Trial In Patients With Mild Alzheimer’s Disease
7/10/2014
-
Helsinn Announces That Phase 2/3 Pivotal Trials For NEPA (Netupitant 300 Mg + Oral Palonosetron 0.50 Mg), Will Be Published In The Annals Of Oncology
7/10/2014
-
Oxygen Biotherapeutics, Inc. Release: Recent Scientific Publications Highlight Potential Benefits Of Levosimendan In Cardiac Surgery And Additional Critical Care Conditions
7/9/2014
-
Vital Therapies, Inc. (VTI) Reports On Clinical Trial Progress And EU Regulatory Advice
7/9/2014
-
La Jolla Pharmaceutical Company Announces Planned Initiation Of Phase 3 Registration Program For LJPC-501 In Resistant Hypotension
7/9/2014
-
San Diego's Otonomy, Inc. Touts Positive Data From Two Phase 3 Trials Of Auripro™
7/8/2014
-
Eli Lilly and Company To Showcase Data From Its Alzheimer's Disease Portfolio At The Alzheimer's Association International Conference 2014 (AAIC 2014)
7/8/2014
-
CEL-SCI Receives Regulatory Clearance To Expand CEL-SCI’S Phase 3 Head And Neck Cancer Trial Into Austria
7/8/2014